Mesenchymal Stem Cells Market 2023 | Growth and Forecast 2028

No comments

According to the latest report by IMARC Group, titled, “Mesenchymal Stem Cells Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” The study provides a detailed analysis of the industry, including the global mesenchymal stem cells market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights:

How big is the mesenchymal stem cells market?

Report Attributes Details
Market Size in 2022 US$ 2.9 Billion
Market Forecast in 2028 US$ 6.16 Billion
Growth rate (2023 to 2028) CAGR of 13.06%
Base Year of the Analysis 2022
Forecast Period 2023-2028

What is mesenchymal stem cells?

Mesenchymal stem cells (MSCs) represent a type of adult stem cell that holds great promise in the field of regenerative medicine. They are present in several tissues in the body, such as bone marrow, adipose tissue (fat), umbilical cord blood, and dental pulp. MSCs possess the remarkable ability to differentiate into multiple types of cells, including bone cells, cartilage cells, muscle cells, and fat cells. They release numerous bioactive molecules, such as cytokines, and extracellular vesicles, which have important roles in tissue regeneration and repair. These molecules can stimulate nearby cells to divide and differentiate, promote the formation of new blood vessels, reduce scarring, and aid in tissue remodeling. Owing to their regenerative potential and their ability to modulate the immune system, MSCs are being extensively studied for an extensive range of therapeutic applications across the globe.

Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/mesenchymal-stem-cells-market/requestsample

Other Post You May Be Interested In

What are the growth prospects and trends in the mesenchymal stem cells industry?

The mesenchymal stem cells market is primarily driven by the inflating healthcare expenditure and the growing prevalence of chronic diseases, especially among the geriatric population across countries. Additionally, the rising demand for effective therapies that can address the underlying causes of these health conditions is acting as another significant growth-inducing factor. In line with this, the elevating use of MSCs in promoting tissue repair and regeneration, making them a potential solution for various medical conditions, is also positively influencing the global market. Moreover, the escalating limitations and safety concerns associated with traditional treatment, the continuous improvements in healthcare infrastructure, and the expanding awareness among the population about the potential benefits of MSC-based therapies are expected to bolster the mesenchymal stem cells market in the coming years.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Product & Services:

  • Products
    • Cells and Cell Lines
    • Kits, Media, and Reagents
    • Others
  • Services

Breakup by Type:

  • Autologous
  • Allogeneic

Breakup by Source of Isolation:

  • Bone Marrow
  • Cord Blood
  • Peripheral Blood
  • Fallopian Tube
  • Fetal Liver
  • Lung
  • Adipose Tissues

Breakup by Indication:

  • Bone and Cartilage Repair
  • Cardiovascular Disease
  • Inflammatory and Immunological Diseases
  • Liver Diseases
  • Cancer
  • GvHD
  • Others

Breakup by Application:

  • Disease Modelling
  • Drug Development and Discovery
  • Stem Cell Banking
  • Tissue Engineering
  • Toxicology Studies

Breakup by Region:

  • North America
  • Asia-Pacific
  • Europe
  • Latin America
  • Middle East and Africa

Who are the key players operating in the industry?

The report covers the major market players including:

  • ATCC
  • Axol Bioscience Ltd.
  • Cell Applications Inc.
  • Celprogen Inc.
  • Cyagen Biosciences Inc.
  • Lonza Group AG
  • Merck KGaA
  • PromoCell GmbH
  • STEMCELL Technologies Inc.
  • Thermo Fisher Scientific Inc.

Ask Analyst for 10% Free Customized Report: https://www.imarcgroup.com/request?type=report&id=8062&flag=C

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact us:

IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Website: https://www.imarcgroup.com/
Follow us on Twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group

SHARE NOW
Tagged with

Leave a Reply

Your email address will not be published. Required fields are marked *